跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 4,933 条关于
“Ken Takeshita”
全部
4,933
临床试验
3,598
药物
416
机构
86
资讯
833
7个月前
Former Novartis CMO John Tsai Appointed Global Head of R&D at Daiichi Sankyo
去年
I-Mab Strengthens Leadership Team with Three New Board Appointments and R&D Committee Formation
去年
AstraZeneca and Daiichi Sankyo Seek FDA Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
2年前
Daiichi Sankyo's DS-9606 Shows Promise in Phase I Trial for Advanced Solid Tumors
2年前
Datopotamab Deruxtecan Fails to Meet Overall Survival Endpoint in TROPION-Breast01 Trial
2年前
Daiichi Sankyo's DS-9606 Shows Promise in Phase I Solid Tumor Trial
2年前
Patritumab Deruxtecan BLA Receives CRL from FDA Due to Manufacturing Inspection
去年
AstraZeneca and Daiichi Sankyo Seek Accelerated Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
4年前
FDA Grants Breakthrough Therapy Designation to Trastuzumab Deruxtecan for HER2-Low Metastatic Breast Cancer
2年前
FDA Accepts Datopotamab Deruxtecan BLA for HR-Positive, HER2-Negative Metastatic Breast Cancer
第 1 页,共 84 页
上一页
下一页